Can Parenteral Drug Delivery Devices Improve Patient Outcomes When Therapies Are Administered at Home?
On June 9th, Oval hosted a roundtable with a panel of industry experts, to discuss the options and challenges facing the future of novel treatments and how advances in parenteral drug delivery can improve patient outcomes outside traditional healthcare settings.
Featuring:
Key Takeaways:
- As people manage their health more actively, drug companies are increasing their focus on patient centered development.
- Successful adoption of parenteral drug delivery devices requires a ‘journey to confidence’ for patients.
- When pharmaceutical companies balance go-to-market time and risk, some defer the release of autoinjectable drugs.
- Pharmaceutical leaders see value in adding connectivity to parenteral delivery devices, but it’s not entirely clear how that value will be realized.
- Multiple factors are driving increased demand for self-administered drugs and autoinjectors.